Tag Archives: Favipiravir

Fujifilm Partners with Carelink in Deploying Anti-influenza Drug Avigan® Tablets in China

Fujifilm Partners with Chinese Pharmaceutical Company Carelink in Deploying Anti-influenza Drug Avigan® Tablets in China TOKYO, October 22, 2020 — FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada) has announced that the company has partnered with Chinese pharmaceutical company Carelink Pharmaceutical Co., Ltd. (hereinafter “Carelink”) in deploying anti-influenza drug Avigan® Tablets (generic name: favipiravir, “Avigan”) in China. […]

Posted in Press releases | Also tagged , , , | Leave a comment

Fujifilm Filed An Application to Provide Dosage And Administration Instructions Concerning COVID-19

Fujifilm Filed an Application for Partial Changes to the Manufacturing and Marketing Approval Matters of Anti-Influenza Drug Avigan® Tablet in Japan to Include Additional Indication for COVID-19 TOKYO, October 16, 2020 — FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada; hereinafter “FUJIFILM Toyama Chemical”) has announced that the company filed an Application for Partial Changes to […]

Posted in Press releases | Also tagged , , , | Leave a comment

Fujifilm Manufacturing Drug Substances For New COVID-19 Antibody Test For Low- and Middle-Income Countries

Eli Lilly and Company of the United States is entrusted with the manufacture of drug substances for antibody drugs for the new coronavirus infection, which aims to spread to low- and middle-income countries. FUJIFILM Diosynth Biotechnologies (FDB), a subsidiary of FUJIFILM Corporation (President: Kenji Sukeno), a contract development and manufacturing company (CDMO) * 2 for biopharmacy * 1 , is Eli Lilly. We are […]

Posted in Press releases | Also tagged , , , | Leave a comment

Fujifilm Started Development of Highly Sensitive and Rapid Antigen Test Kit For New Coronavirus

Started Development of Highly Sensitive and Rapid Antigen Test Kit For New Coronavirus Applying silver halide amplification technology for photo development FUJIFILM Corporation (President: Kenji Sukeno) has started the development of a new coronavirus (SARS-CoV-2) antigen test kit. We aim to put the new coronavirus antigen test kit into practical use at an early stage by using […]

Posted in Press releases | Also tagged , , , | Leave a comment

Fujifilm Concludes a Manufacturing Contract Agreement with VLP Therapeutics, for a COVID-19 Vaccine Formulation

Fujifilm Concludes a Manufacturing Contract Agreement with VLP Therapeutics, for a COVID-19 Vaccine Formulation – Process development and manufacture of formulations using lipid nanoparticles Drug Delivery System technology – TOKYO, October 1, 2020 — FUJIFILM Corporation (President: Kenji Sukeno) announces the conclusion of a manufacturing contract agreement with biotechnology company, VLP Therapeutics Japan LLC (Representative […]

Posted in Press releases | Also tagged , , , | Leave a comment

Avigan Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19

Anti-influenza drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients TOKYO, September 23, 2020 — FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada; hereinafter “FUJIFILM Toyama Chemical”) has announced today that primary endpoint has been met in phase III clinical trial of “Avigan Tablet” (generic name: favipiravir, “Avigan”) conducted […]

Posted in Press releases | Also tagged , , , | Leave a comment